BPMC
Blueprint Medicines
BPMC
BPMC
Delisted
BPMC was delisted on the 17th of July, 2025.
138 hedge funds and large institutions have $2.53B invested in Blueprint Medicines in 2017 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 51 increasing their positions, 40 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
14% more funds holding in top 10
Funds holding in top 10: 7 → 8 (+1)
11% more funds holding
Funds holding: 124 → 138 (+14)
0.85% more ownership
Funds ownership: 91.9% → 92.75% (+0.85%)
Holders
138
Holding in Top 10
8
Calls
$3.51M
Puts
$2.63M
Top Buyers
| 1 | +$39.5M | |
| 2 | +$36.1M | |
| 3 | +$23.9M | |
| 4 |
TCM
TimesSquare Capital Management
New York
|
+$21.4M |
| 5 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$21.4M |
Top Sellers
| 1 | -$40.7M | |
| 2 | -$26.5M | |
| 3 | -$20.4M | |
| 4 |
RG
Redmile Group
San Francisco,
California
|
-$18.6M |
| 5 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$15.5M |